Mary Crowley Cancer Research Centers Achieve Dramatic Improvements in Financial Infrastructures With Velos eResearch and Net.Orange Systems
Velos, Inc., the recognized leader and trusted resource for clinical research management information systems, and Net.Orange, Inc., the respected healthcare Internet solutions company, have partnered with the highly-regarded Mary Crowley Cancer Research Centers (Mary Crowley). The two companies have helped Mary Crowley to achieve best practices for strong central clinical research infrastructure and implementation of an enterprise-wide system of financial responsibility.
The Quantum Group Announces Strategic Technology Alliance Partners with Net.Orange to provide industry-wide solution
The Quantum Group, Inc. (AMEX:QGP, QGP.WSA, QGP.WSB) (www.QuantumMD.com) today announced a multi-dimensional, six year alliance established by Quantum wholly-owned subsidiary Quantum Medical Technologies, Inc. with Texas-based Net.Orange, Inc., inventor of the revolutionary cOS™ (Clinical Operating System) and many general and therapeutic-specific technology solutions.
The Independent Doctors of New Mexico, Inc, (IDNM) Advances to integration Strategy
The Independent Doctors of New Mexico, Inc. has engaged Texas-based Net.Orange, Inc., inventor of the revolutionary cOS™ (Clinical Operating System) and many general and therapeutic-specific technology solutions, to develop IDNM's clinical integration system to complement the Financial Integration system previously developed by Net.Orange, Inc.
Net.Orange Inc. and the Mary Crowley Cancer Research Centers announce expansion of strategic collaboration
The Mary Crowley Cancer Research Centers (MCCRC) today announced an expansion of its strategic collaboration with Texas-based Net.Orange Inc., inventor of the revolutionary cOS™ (Clinical Operating System) and many general and therapeutic-specific technology solutions.
Net.Orange is proud to announce that the Running for Bella 5K Race, held in Norman, OK on March 24th, 2007, was a great success. We were excited to have been the Sponsor for such a great cause and to be at the forefront of raising more than $15,000 for Isabella Stringer and Lissencephaly Research.